PharmaCyte Biotech Inc (PMCB)

[A2Z]

Can anyone give me a scenario of possibly how it works if PMCB would be bought out. Whom ever it might be would it be just the pancreatic cancer part or do they get lock stock and barrel... the diabetic too. After all we are a delivery system. So would a buyer just get it for the pancreatic part only and all others would be still owned by PMCB

If it is just the pancreatic part does the buyer own the pmcb name and technology of CIAB for just the delivery of the pancreatic part.

If they get the pancreatic part then do they get part of austronovia too the 14%. A handful of us are confused as to how it may turn out of who still owns what. Any info or scenario would be much appreciated.